Remote Guided Caffeine Reduction

NCT04560595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

The purpose of this online research study is to determine whether or not a gradual caffeine reduction program developed at Johns Hopkins can help people reduce their caffeine use. The investigators will provide materials to help guide caffeine reduction and ask questions to track caffeine use over several weeks. The investigators will also assess how reducing caffeine may benefit common caffeine-related problems such as anxiety, sleep disturbances, and gastrointestinal distress. The study will also determine whether or not people like participating in this caffeine reduction program in an online format.

Conditions

  • Caffeine Dependence
  • Anxiety
  • Sleep Disturbance
  • Gastrointestinal Dysfunction
  • Sleep Initiation and Maintenance Disorders
  • Caffeine; Sleep Disorder
  • Caffeine
  • Caffeine-Induced Anxiety Disorder
  • Caffeine Withdrawal
  • Caffeine-Induced Sleep Disorder, Without Use Disorder
  • Caffeine Abuse
  • Insomnia
  • Anxiety Disorders
  • Sleep Disorder
  • Heartburn
  • Diarrhea

Interventions

BEHAVIORAL

Caffeine Reduction Manual

We will provide participants with a Guide to Caffeine Reduction and Cessation in order to help the reduce their caffeine use and determine their ratings of treatment acceptability.

Sponsors & Collaborators

Principal Investigators

  • Dustin Lee, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-10
Primary Completion
2023-08-01
Completion
2023-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04560595 on ClinicalTrials.gov